Alex Dobbin | Head-Investor Relations |
Rick Winningham | Chief Executive Officer |
Brett Haumann | Chief Medical Officer |
Renée Galá | Chief Financial Officer |
Josh Schimmer | Evercore ISI |
Brian Skorney | Robert W. Baird |
Louise Chen | Cantor |
Ladies and gentlemen, good afternoon. At this time, I'd like to welcome everyone to the Theravance Biopharma Conference Call. [Operator Instructions] Today's conference call is being recorded. And now, I would like to turn the call over to Alex Dobbin, Head of Investor Relations. Please go ahead.